The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Sulfonamide derivatives as multi-target agents for complex diseases
Open accessAbstract
Sulfonamide derivatives are frequently seen structural motifs in medicinal chemistry. Almost a century after Gerhard Domagk's pioneering work leading to the first sulfonamide antibiotic Prontosil, sulfa-drugs are still widely utilized in various pharmaceutical applications due to their antibacterial, antiviral, antimalarial, antifungal, anticancer, antidepressant, or other properties. In the past few years, the interest in sulfonamides has increased as their broad range of bioactivity and versatile structure make them excellent candidates for repurposing old drugs or developing new multi-target agents in the emerging field of polypharmacology. This digest aims to provide an overview of recent advances in sulfonamide-based bioactive compounds, their importance in drug discovery and development emphasizing multi-target approaches for complex diseases, and their novel contribution to contemporary medicinal chemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Shifting from the single to the multitarget paradigm in drug discovery
Medina-Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.008 · Cited by 483
Guzior, N., Wi.eckowska, A., Panek, D., & Malawska, B. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106122628 · Cited by 323
Sulfonimidamides in Medicinal and Agricultural Chemistry
Chinthakindi, P. K., Naicker, T., Thota, N., Govender, T., Kruger, H. G., & Arvidsson, P. I. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610456 · Cited by 271
Polypharmacology in a Single Drug: Multitarget Drugs
L. Bolognesi, M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130004 · Cited by 230
Barbaro, G., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764869 · Cited by 222
A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease
Sameem, B., Saeedi, M., Mahdavi, M., & Shafiee, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.060 · Cited by 194
Ismaili, L., Refouvelet, B., Benchekroun, M., Brogi, S., Brindisi, M., Gemma, S., Campiani, G., Filipic, S., Agbaba, D., Esteban, G., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.003 · Cited by 178
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
Košak, U., Brus, B., Knez, D., Šink, R., Žakelj, S., Trontelj, J., Pišlar, A., Šlenc, J., Gobec, M., Živin, M., et al. (2016) · Scientific Reports · doi:10.1038/srep39495 · Cited by 163
Košak, U., Brus, B., Knez, D., Žakelj, S., Trontelj, J., Pišlar, A., Šink, R., Jukič, M., Živin, M., Podkowa, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01086 · Cited by 160
Garaj, V., Puccetti, L., Fasolis, G., Winum, J., Montero, J., Scozzafava, A., Vullo, D., Innocenti, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.056 · Cited by 149
Sabt, A., Abdelhafez, O. M., El-Haggar, R. S., Madkour, H. M. F., Eldehna, W. M., El-Khrisy, E. E.-D. A. M., Abdelrahman, M. A., & Rashed, L. A. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1477137 · Cited by 112
Multi-Target Approach for Drug Discovery against Schizophrenia
Kondej, M., Stępnicki, P., & Kaczor, A. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103105 · Cited by 109
Garaj, V., Puccetti, L., Fasolis, G., Winum, J., Montero, J., Scozzafava, A., Vullo, D., Innocenti, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.087 · Cited by 107
Peerzada, M. N., Κhan, P., Ahmad, K., Hassan, M. I., & Azam, A. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.034 · Cited by 101
Knez, D., Coquelle, N., Pišlar, A. H., Žakelj, S., Jukič, M., Sova, M., Mravljak, J., Nachon, F., Brazzolotto, X., Kos, J., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.033 · Cited by 98
Quinoline- and Isoquinoline-Sulfonamide Analogs of Aripiprazole: Novel Antipsychotic Agents?
Zajdel, P., Partyka, A., Marciniec, K., Bojarski, A. J., Pawłowski, M., & Wesołowska, A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.158 · Cited by 95
Więckowska, A., Kołaczkowski, M., Bucki, A., Godyń, J., Marcinkowska, M., Więckowski, K., Zaręba, P., Siwek, A., Kazek, G., Głuch-Lutwin, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.016 · Cited by 91
Sulfonamides as multifunctional agents for Alzheimer’s disease
Bag, S., Tulsan, R., Sood, A., Cho, H., Redjeb, H., Zhou, W., LeVine, H., Török, B., & Török, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.006 · Cited by 89
Self-citationRiaz, S., Khan, I. U., Bajda, M., Ashraf, M., Qurat‐ul‐Ain, Shaukat, A., Rehman, T. U., Mutahir, S., Hussain, S., Mustafa, G., et al. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.09.008 · Cited by 77
Mutahir, S., Jończyk, J., Bajda, M., Khan, I. U., Khan, M. A., Ullah, N., Ashraf, M., Qurat‐ul‐Ain, Riaz, S., Hussain, S., et al. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.11.002 · Cited by 73
Kołaczkowski, M., Marcinkowska, M., Bucki, A., Pawłowski, M., Mitka, K., Jaśkowska, J., Kowalski, P., Kazek, G., Siwek, A., Wasik, A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401895u · Cited by 69
Košak, U., Knez, D., Coquelle, N., Brus, B., Pišlar, A. H., Nachon, F., Brazzolotto, X., Kos, J., Colletier, J., & Gobec, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.032 · Cited by 67
Gawad, N. M. A., Amin, N. H., El‐Saadi, M. T., Mohamed, F. M. M., Angeli, A., Luca, V. D., Capasso, C., & Supuran, C. T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.016 · Cited by 59
Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease
Więckowska, A., Wichur, T., Godyń, J., Bucki, A., Marcinkowska, M., Siwek, A., Więckowski, K., Zaręba, P., Knez, D., Głuch‐Lutwin, M., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00024 · Cited by 55
Zajdel, P., Kos, T., Marciniec, K., Satała, G., Canale, V., Kamiński, K., Hołuj, M., Lenda, T., Koralewski, R., Bednarski, M., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.002 · Cited by 52
Marques, S. M., Enyedy, É. A., Supuran, C. T., Krupenko, N. I., Krupenko, S. A., & Santos, M. A. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.072 · Cited by 51
Yahiaoui, S., Hamidouche, K., Ballandonne, C., Davis, A., Santos, J. S. O., Fréret, T., Boulouard, M., Rochais, C., & Dallemagne, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.048 · Cited by 49
Koyuncu, İ., Gönel, A., Koçyiğit, A., Temiz, E., Durgun, M., & Supuran, C. T. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1481403 · Cited by 44
Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase
Gu, S., Xue, P., Ju, X.-L., & Zhu, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.025 · Cited by 41
Havránková, E., Csöllei, J., Vullo, D., Garaj, V., Pazdera, P., & Supuran, C. T. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.12.034 · Cited by 41
Hangan, A. C., Borodi, G., Lucaciu, R. L., Páll, E., Cenariu, M., Oprean, L. S., & Sevastre, B. (2018) · Inorganica Chimica Acta · doi:10.1016/j.ica.2018.07.045 · Cited by 40
Ain, Q. U., Méndez‐Lucio, O., Cortés‐Ciriano, I., Malliavin, T. E., van Westen, G. J. P., & Bender, A. (2014) · Integrative Biology · doi:10.1039/c4ib00175c · Cited by 37
Ulus, R., Kurt, B. Z., Gazioğlu, I., & Kaya, M. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.01.005 · Cited by 36
Ghareb, N., El-Sayed, N. M., Abdelhameed, R. F. A., Yamada, K., & Elgawish, M. S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.01.052 · Cited by 36
Abdel‐Maksoud, M. S., El–Gamal, M. I., El‐Din, M. M. G., & Oh, C. H. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1530225 · Cited by 35
Pero, J. E., Matthews, J. M., Behm, D. J., Brnardic, E. J., Brooks, C. A., Budzik, B., Costell, M. H., Donatelli, C. A., Eisennagel, S., Erhard, K. F., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01344 · Cited by 34
Rajeshwari, R., Chand, K., Candeias, E., Cardoso, S. M., Chaves, S., & Santos, M. A. (2019) · Molecules · doi:10.3390/molecules24030587 · Cited by 31
Guo, Z., Xu, Y., Peng, Y., Rashid, H. U., Quan, W., Xie, P., Wu, L., Jiang, J. R., Wang, L., & Liu, X. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.02.023 · Cited by 31
Lu, T., Laughton, C. A., Wang, S., & Bradshaw, T. D. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093245 · Cited by 30
Tassini, S., Sun, L., Lanko, K., Crespan, E., Langron, E., Falchi, F., Kiššová, M., Rivera, J. I. A., Delang, L., Mirabelli, C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01521 · Cited by 30
Gao, D., Dou, H., Su, H., Zhang, M., Wang, T., Liu, Q.-F., Cai, H., Ding, H.-P., Yang, Z., Zhu, W., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.007 · Cited by 29
A novel antibiotic-delivery system by using ovotransferrin as targeting molecule
Ibrahim, H. R., Tatsumoto, S., Ono, H., Immerseel, F. V., Raspoet, R., & Miyata, T. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.10.005 · Cited by 23
Wang, Y., Zhao, H., Brewer, J. T., Li, H., Lao, Y., Amberg, W., Behl, B., Akritopoulou‐Zanze, I., Dietrich, J. D., Lange, U. E. W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00295 · Cited by 23
Golestanian, S., Sharifi, A., Popowicz, G. M., Azizian, H., Foroumadi, A., Szwagierczak, A., Holak, T. A., & Amanlou, M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.047 · Cited by 22
Gamage, S. A., Giddens, A. C., Tsang, K. Y., Flanagan, J. U., Kendall, J. D., Lee, W.-J., Baguley, B. C., Buchanan, C. M., Jamieson, S. M. F., Shepherd, P. R., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.025 · Cited by 21
Markowicz-Piasecka, M., Huttunen, K. M., Mateusiak, Ł., Mikiciuk‐Olasik, E., & Sikora, J. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.02.012 · Cited by 21
Giddens, A. C., Gamage, S. A., Kendall, J. D., Lee, W.-J., Baguley, B. C., Buchanan, C. M., Jamieson, S. M. F., Dickson, J. M. J. J., Shepherd, P. R., Denny, W. A., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.02.050 · Cited by 18
Aβ regulation-based multitarget strategy for drug discovery against Alzheimer’s disease
Guo, X., Jiang, W., Li, C., Zhu, Z., & Shen, X. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0064 · Cited by 7
Cited by
Tay, N. E. S., Lehnherr, D., & Rovis, T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00384 · Cited by 518
Makhaeva, G. F., Kovaleva, N. V., Boltneva, N. P., Lushchekina, S. V., Astakhova, T. Y., Rudakova, E. V., Proshin, A. N., Serkov, I. V., Radchenko, E. V., Palyulin, V. A., et al. (2020) · Molecules · doi:10.3390/molecules25173915 · Cited by 53
“Sulfonamides are widely utilized in various pharmaceutical applications due to their therapeutic versatility that encompasses antibacterial, antiviral, antimalarial, antifungal, anticancer, antidepressant, and other properties [58,59].”
Background
Metadata
- Authors
- Apaydın, S., & Török, M.
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 29
- Issue
- 16
- Pages
- 2042-2050
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W2954109746
- Cited by
- 256
- References
- 49
- FWCI
- 16.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.